BioDot Inc. (BioDot or the Company), a leading manufacturer of automated ultralow volume fluid dispensing systems, announced today that it has been acquired by Artemis Capital Partners (Artemis), a Boston-based private equity firm focused exclusively on partnering with differentiated industrial technology companies. Since its founding in 1994, BioDot has become an undisputed leader in the development of automated low volume liquid handling systems for mission-critical applications. With a unique patent portfolio in low volume dispensing and novel applications, BioDot delivers testing and manufacturing solutions for its customers globally. From R&D to high-throughput point of care assay production, BioDot continues to innovate and partner across the biotechnology, diagnostic, industrial, life science and medical device end markets.
Read the full article: BioDot Acquired by Artemis //
Source: https://www.prnewswire.com/news-releases/biodot-acquired-by-artemis-301037617.html